In a recent study, talk therapy in Parkinson’s disease led to significant improvement in patients' well-being, ...
The glucagon-like peptide-1 receptor agonist exenatide does not yield improvement in measures of Parkinson disease severity.
ThePrint on MSN11h
No incisions, no pain—AIIMS Delhi 1st govt hospital to treat neuro conditions with ultrasonic beamsMagnetic Resonance-guided Focused Ultrasound tech has the potential to treat conditions like essential tremors & Parkinson’s, ...
Gene Mack, Gain Therapeutics CEO, provides a look into the future of the company and the use of physics-based artificial ...
Discover how MR-guided focused ultrasound offers a revolutionary non-invasive treatment for tremors and epilepsy reducing symptoms without surgery or implants ...
Vattikuti Foundation- AIIMS join hands to offer succour to Parkinson's, essential tremors patients: Our Bureau, Mumbai Friday ...
Bayer subsidiary BlueRock Therapeutics has been granted a fast-track review by the FDA for DA01, its stem cell-based therapy for Parkinson's disease which is currently in early-stage clinical testing.
An enzyme called cyclin-dependent kinase 2 (CDK2) regulates the cell cycle and may have the potential to drive therapeutic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback